Recently, exciting clues have emerged in CELF1 research, discovering a small molecule inhibitor (compound 1) that effectively inhibits CELF1 binding activity and is considered a potential therapeutic approach for liver fibrosis. Here, CELF1 is linked to Hepatic fibrosis.